Form D · Biotechnology
Aquyre Biosciences, Inc.
Weston, MA · CIK 0001887377
Offering snapshot reported Oct 23, 2023 · SEC filing
- Reported sold
- $3.22M Offering amount: $10M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2023 | Initial | $3,220,502 | No comparison | 2 | SEC filing |
| May 27, 2022 | Amendment | $5,423,710 | $423,715vs May 13, 2022 | 3 | SEC filing |
| May 13, 2022 | Amendment | $4,999,995 | $1,337,895vs Apr 14, 2022 | 3 | SEC filing |
| Apr 14, 2022 | Amendment | $3,662,100 | $1,662,100vs Mar 9, 2022 | 2 | SEC filing |
| Mar 9, 2022 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Oct 13, 2021 | Initial | $19,945,190 | No comparison | 71 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.31M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-495408
Estimated Selling Commissions and other expenses of Placement Agents
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| More than five (5) Associated Persons | None | Aegis Capital Corp. · CRD 15007 |
| Melior Capital Management Gmbh | None | Weild & Co. · CRD 132398 |
| Invescore Limited | None |
Source: Form D, filed Oct 23, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Albin | Director |
| Ari Azhir | Director |
| Claude Boccara | Executive |
| Gregory Bowles | Executive |
| Floyd Samuel Eberts, Iii | Director, Executive |
| Aurelio Fernandez | Director |
| Francois Grammont | Executive |
| Bertrand Le Conte Chrestien De Poly | Director, Executive |
| Aldo Maccari | Director |
| Richard Mc Cann | Executive |
| Cosme Ordonez | Director |
| Ronald James Sorenson | Director |
| Thierry Thaure | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
133 Boston Post Road
Weston, MA, 02493
Weston, MA, 02493